Page 183 - BSAVA Guide to Pain Management in Small Animal Practice
P. 183

BSAVA Guide to Pain Management in Small Animal Practice



        VetBooks.ir  Drug  Notes*                          Dose     Author
                                                           range in
                                                                    recommendations
                                                                    and guidance
                                                           literature*
            NSAIDs continued
            Carprofen  •   uch work is needed to determine appropriate   1         4 mg kg   4h
                        doses, dosing routes, and dosing fre uency of   mg kg  Use with caution as
                        carprofen in birds                          there are very limited
                      •  1 mg kg improved the speed and walking ability of   data
                        lame chickens but another study showed    mg kg
                        i.m. was needed for analgesia
                      •    mg kg i.m.  1 h was e ective initially but the action
                        was very short lived
             lunixin  •  Used at a wide variety of doses in several avian      .     Not recommended due
                        species but reports in many species associated with   mg kg i.m.  to potential renal e ects
                        glomerular lesions even at low doses
            Local anaesthetics
            Lidocaine  •  Use formulation  without adrenaline    .  1       mg kg perineurally
                      •   ide ranges used  up to 1  mg kg  but not always   mg kg  Use with caution to avoid
                        shown to be e ective                        overdose and toxicity
                      •  Empirical dosing generally accepted to be     mg kg
            Bupi      •  Used with caution in birds due to its longer duration     8      mg kg perineurally
            vacaine     of action and potential for toxic e ects to take longer   mg kg  Use with caution to avoid
                        to resolve                                  overdose and toxicity
                      •  Potential for delayed toxicity at 6 and 1  hours
            Other
             abapentin  •  Precise mechanism of action unknown  1  mg kg   Never been used by this
                      •  Considered synergistic with other drugs  orally  1 h  author
                      •  Stepwise increases in dose thought to be re uired  Refer to literature dose
             ietary   •  No studies have been conducted in birds evaluating   Unknown   ose empirically based
            supplements  e cacy                                     on other species
                      •   lucosamine, chondroitin and Boswelia extract may    ost  oint supplements
                        be bene cial in the treatment of osteoarthritis   have a wide safety
                        through their anti in ammatory e ects       margin so safe to use,
                      •  Polysulfated glycosaminoglycans  PS A s  have   even if e cacy in birds is
                        been used anecdotally but fatal coagulopathies in   unproven
                        di erent avian species have been reported   Avoid PS A s in birds
            Physical   •  Application of ad unctive therapy should be       hese methods are
            therapy     considered for acute and chronic pain, but there is no   worth trying if available
                        evidence of e cacy in birds to date         and the owner is able to
                      •   hermotherapy and lasers may diminish pain   carry them out without
                        decrease indicators of neuropathic pain     causing increased stress
                      •  Anecdotal reports of e cacy of acupuncture  to the bird
                      •  Cold and or heat therapy has been shown to be
                        e ective in other species
                      •  Photobiomodulation therapy  coid laser

                   continued  Analgesia drugs used in birds.  Information referenced from  awkins et al.,   16.
               3   CRI   continuous rate infusion;  AC   mean anaesthetic concentration; NSAI    non steroidal anti
           in ammatory drug; P    pharmacodynamic; P    pharmacokinetic.

           178



         Ch07J Pain Management.indd   178                                       19/12/2018   10:47
   178   179   180   181   182   183   184   185   186   187   188